Bladder Cancer Stocks List

Recent Signals

Date Stock Signal Type
2019-10-11 ANCN Narrow Range Bar Range Contraction
2019-10-11 HTBX Lower Bollinger Band Walk Weakness
2019-10-11 HTBX NR7 Range Contraction
2019-10-11 NEO 20 DMA Resistance Bearish
2019-10-11 SESN 50 DMA Resistance Bearish
2019-10-11 SESN NR7 Range Contraction
2019-10-11 SESN NR7-2 Range Contraction
2019-10-11 SESN Narrow Range Bar Range Contraction

Bladder cancer is any of several types of cancer arising from the tissues of the urinary bladder. It is a disease in which cells grow abnormally and have the potential to spread to other parts of the body. Symptoms include blood in the urine, pain with urination, and low back pain.Risk factors for bladder cancer include smoking, family history, prior radiation therapy, frequent bladder infections, and exposure to certain chemicals. The most common type is transitional cell carcinoma. Other types include squamous cell carcinoma and adenocarcinoma. Diagnosis is typically by cystoscopy with tissue biopsies. Staging of the cancer is typically determined by medical imaging such as CT scan and bone scan.Treatment depends on the stage of the cancer. It may include some combination of surgery, radiation therapy, chemotherapy, or immunotherapy. Surgical options may include transurethral resection, partial or complete removal of the bladder, or urinary diversion. Typical five-year survival rates in the United States are 77%.Bladder cancer, as of 2015, affects about 3.4 million people globally with 430,000 new cases a year. In 2015 it resulted in 188,000 deaths. Age of onset is most often between 65 and 85 years of age. Males are more often affected than females. In the United States in 2018 81,000 cases and 17,000 deaths are expected making it the 6th most common type of cancer in the region.

More about Bladder Cancer